{"database": "lobbying", "table": "lobbying_activities", "rows": [[2774250, "e3fd2cc6-bb36-42b4-9ed8-a98fceb056cf", "Q1", "FAMILIES USA FOUNDATION, INC.", 14108, "FAMILIES USA FOUNDATION INC", 2022, "first_quarter", "MED", "S.1644Promising Pathway ActTo amend the Federal Food, Drug, and CosmeticActto establish a time-limited provisional approvalpathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2022-04-14T14:36:36-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2774250"], "units": {}, "query_ms": 0.4448289982974529, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}